NCLT approves SeQuent Scientific and Viyash Lifesciences merger
after close1 source ↓written by the desknot a recommendation
The National Company Law Tribunal (NCLT) has approved the merger between SeQuent Scientific and Viyash Lifesciences. This merger aims to enhance scale and capabilities in the Animal Health market, providing financial resilience and accelerating organic growth. The combined entity is set to leverage strengths in R&D and manufacturing to deliver world-class solutions.
Not investment advice. For informational purposes only.